INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹808 Cr | ₹645 Cr | ₹481 Cr | ₹518 Cr | ₹407 Cr |
What is the latest Total Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹808 Cr |
| Mar2024 | ₹645 Cr |
| Mar2023 | ₹481 Cr |
| Mar2022 | ₹518 Cr |
| Mar2021 | ₹407 Cr |
How is Total Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹808 Cr | 25.25 | |
| Mar2024 | ₹645 Cr | 34.26 | |
| Mar2023 | ₹481 Cr | -7.21 | |
| Mar2022 | ₹518 Cr | 27.34 | |
| Mar2021 | ₹407 Cr | - | |
Compare Total Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,834.5 Cr | -0.6% | -7.5% | -18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -0.6% |
-7.5% |
-18.3% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses